Kasra Rezaei, MDAssociate Professor; Associate Chief of Service for Ophthalmic Surgery
Medical School: Azad University, Tehran, Iran, 2001
Internship: General Surgery, Vanderbilt University, 2009
Residency: Vanderbilt Eye Institute, Vanderbilt University, 2012
Fellowship: Vitreo-Retinal Fellowship, Associated Retina Consultants, 2014
Board Certification: American Board of Ophthalmology, 2014
Memberships: American Academy of Ophthalmology (AAO)
Subspecialty memberships: The American Society of Retina Surgeons
Dr. Rezaei completed his vitreoretinal fellowship at the Associated Retina Consultants in Phoenix, Arizona. He performed his residency at the Department of Ophthalmology, Vanderbilt University. Dr. Rezaei has an extensive research background in macular degeneration from both the University of Chicago and Vanderbilt University. His research has resulted in publications in prestigious peer-reviewed journals and was presented at national meetings.
Dr. Rezaei’s clinical interests include the management of complex retinal detachments, diabetic retinopathy, retinal vascular occlusions, and age-related macular degeneration. In addition to his interest in taking care of patients and medical research, Dr. Rezaei is an avid athlete and has finished multiple marathons in the past few years.
Location: 908 Jefferson St., 7th Floor Seattle, WA Clinic Phone: 206-744-2020 Clinic Fax: 206-520-9310 Mailing Address: Box 359608 325 Ninth Ave. Seattle, WA 98104 Academic Phone: 206-543-7250
Patient Care Philosophy
‘’It is a great honor to participate in the care of patients and improve their vision and quality of life."
Awards and honors
2010 Selected to attend the 5th annual Heed Foundation Resident’s Retreat
2006 Illinois Society to Prevent Blindness Research Grant
2005 Illinois Society to Prevent Blindness Research Grant
Dr. Rezaei’s clinical interests include the management of complex retinal detachments, diabetic retinopathy, retinal vascular occlusions, and age-related macular degeneration.
Dr. Rezaei’s research includes the development of a new generation of optical coherence tomography in the diagnosis of diabetic retinopathy, age-related macular degeneration, and vein occlusion.